Health

W.H.O. ADVISES AGAINST USE OF TWO ANTI-BODIES FOR COVID-19

W.H.O. ADVISES AGAINST USE OF TWO ANTI-BODIES FOR COVID-19

NEW DELHI, Sep. 18, 2022 (TBINN)

Two COVID-19 anti-body treatments are no longer recommended by the World Health Organisation because OMICRON and its sub-variants have likely rendered them obsolete, according to a revised guideline published in the British Medical Journal.

In the same guideline update, W.H.O. makes a conditional recommendation for the use of the anti-viral drug Remdesivir in patients with severe COVID-19 and a conditional recommendation against its use in patients with critical disease.

The W.H.O. Guideline Development Group of international experts noted that anti-body drugs Sotrovimab and Casirivimab-imdevimab are not recommended for patients with COVID-19.

About the author

The Bharat India

TheBharat-A Media Initiative of ITM is India's Best Hindi /English News Channel.TheBharat-A Media Initiative of ITM News Channel Covers The Latest News, Breaking News, Politics, Entertainment News, Business News and Sports News. Stay tuned for all the News in Hindi/English.

Add Comment

Click here to post a comment